20 LATEST RESOURCES (22 INDEXED)
No Evidence for Clinical Efficacy of Adjunctive Celecoxib with Vortioxetine in the Treatment of Depression: A 6-Week Double-Blind Placebo Controlled Randomized Trial · August 2021
Abstracts
European Neuropsychopharmacology
The Effect of Single Administration of Intravenous Ketamine Augmentation on Suicidal Ideation in Treatment-Resistant Unipolar Depression: Results from a Randomized Double-Blind Study · June 2021
Abstracts
European Neuropsychopharmacology
Aripiprazole vs Risperidone for the Acute-Phase Treatment of First-Episode Psychosis: A 6-Week Randomized, Flexible-Dose, Open-Label Clinical Trial · March 2021
Abstracts
European Neuropsychopharmacology
Aripiprazole Monotherapy as Transdiagnostic Intervention for the Treatment of Mental Disorders: An Umbrella Review According to TRANSD Criteria · October 2020
Abstracts
European Neuropsychopharmacology
A 3-Year Prospective Study on the Metabolic Effect of Aripiprazole, Quetiapine and Ziprasidone: A Pragmatic Clinical Trial in First Episode Psychosis Patients · September 2020
Abstracts
European Neuropsychopharmacology
Bupropion, a Possible Antidepressant without Negative Effects on Alcohol Relapse · May 2019
Abstracts
European Neuropsychopharmacology
Combined Fluvoxamine and Extended-Release Methylphenidate Improved Treatment Response Compared to Fluvoxamine Alone in Patients with Treatment-Refractory Obsessive-Compulsive Disorder: A Randomized Double-Blind, Placebo-Controlled Study · December 2018
Abstracts
European Neuropsychopharmacology
Dose Reduction of High-Dose First-Generation Antipsychotics or Switch to Ziprasidone in Long-Stay Patients with Schizophrenia: A 1-Year Double-Blind Randomized Clinical Trial · July 2018
Abstracts
European Neuropsychopharmacology
12-Week Double-Blind Randomized Multicenter Study of Efficacy and Safety of Agomelatine (25-50 Mg/Day) versus Escitalopram (10-20 Mg/Day) in Out-Patients with Severe Generalized Anxiety Disorder · July 2018
Abstracts
European Neuropsychopharmacology
Randomized Trial of Omega-3 for Autism Spectrum Disorders: Effect on Cell Membrane Composition and Behavior · September 2017
Abstracts
European Neuropsychopharmacology
Benefits and Harms of Atypical Antipsychotics for Agitation in Adults with Dementia · January 2017
Abstracts
European Neuropsychopharmacology
Association of Plasma Calcium Concentrations with Alcohol Craving: New Data on Potential Pathways · November 2016
Abstracts
European Neuropsychopharmacology
Autistic Spectrum Disorder in Adults with Obsessive Compulsive Disorder: Results from a UK Survey · May 2016
Abstracts
European Neuropsychopharmacology
Benzodiazepines and Risk of Death: Results from Two Large Cohort Studies in France and UK · July 2015
Abstracts
European Neuropsychopharmacology
Recurrence Rates in Bipolar Disorder: Systematic Comparison of Long-Term Prospective, Naturalistic Studies versus Randomized Controlled Trials · July 2015
Abstracts
European Neuropsychopharmacology
Mirtazapine in Pregnancy and Lactation: A Systematic Review · June 2015
Abstracts
European Neuropsychopharmacology
Anti-Depressant Therapy and Cancer Risk: A Nested Case-Control Study · April 2015
Abstracts
European Neuropsychopharmacology
Treatment with Ziprasidone for Schizophrenia Patients with OCD · July 2014
Abstracts
European Neuropsychopharmacology
Ziprasidone with Adjunctive Mood Stabilizer in the Maintenance Treatment of Bipolar I Disorder: Long-Term Changes in Weight and Metabolic Profiles · July 2011
Abstracts
European Neuropsychopharmacology
Antipsychotic Augmentation of Serotonergic Antidepressants in Treatment-Resistant Obsessive-Compulsive Disorder: A Meta-Analysis of the Randomized Controlled Trials · August 2006
Abstracts (Summaries)
University of York>European Neuropsychopharmacology